Annual SGA
$10.69 M
-$9.76 M-47.71%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual SGA is $10.69 million, with the most recent change of -$9.76 million (-47.71%) on December 31, 2022.
- During the last 3 years, ELOX annual SGA has fallen by -$13.51 million (-55.83%).
- ELOX annual SGA is now -59.63% below its all-time high of $26.48 million, reached on December 31, 2018.
Performance
ELOX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.39 M
+$585.00 K+32.46%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly SGA is $2.39 million, with the most recent change of +$585.00 thousand (+32.46%) on September 30, 2023.
- Over the past year, ELOX quarterly SGA has increased by +$125.00 thousand (+5.53%).
- ELOX quarterly SGA is now -75.03% below its all-time high of $9.56 million, reached on June 30, 2018.
Performance
ELOX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.13 B
-$20.48 M-1.85%
September 30, 2023
Summary
- As of February 8, 2025, ELOX TTM SGA is -$1.13 billion, with the most recent change of -$20.48 million (-1.85%) on September 30, 2023.
- Over the past year, ELOX TTM SGA has dropped by -$1.14 billion (-9762.78%).
- ELOX TTM SGA is now -51196.18% below its all-time high of -$2.20 million.
Performance
ELOX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ELOX Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -47.7% | +5.5% | -9762.8% |
3 y3 years | -55.8% | -16.3% | -6736.8% |
5 y5 years | +295.7% | -68.5% | -4762.1% |
ELOX Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -47.7% | at low | -35.8% | +32.5% | -31.0% | at low |
5 y | 5-year | -55.8% | at low | -67.5% | +32.5% | -138.6% | at low |
alltime | all time | -59.6% | +988.4% | -75.0% | +863.1% | <-9999.0% | at low |
Eloxx Pharmaceuticals Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | $2.39 M(+32.5%) | $8.91 M(+1.4%) |
Jun 2023 | - | $1.80 M(-9.7%) | $8.79 M(-8.8%) |
Mar 2023 | - | $2.00 M(-26.9%) | $9.63 M(-9.9%) |
Dec 2022 | $10.69 M(-47.7%) | $2.73 M(+20.7%) | $10.69 M(-8.5%) |
Sep 2022 | - | $2.26 M(-14.5%) | $11.68 M(-19.2%) |
Jun 2022 | - | $2.65 M(-13.4%) | $14.45 M(-24.6%) |
Mar 2022 | - | $3.05 M(-17.9%) | $19.16 M(-6.3%) |
Dec 2021 | $20.45 M(+37.7%) | $3.72 M(-26.2%) | $20.45 M(+2.9%) |
Sep 2021 | - | $5.04 M(-31.5%) | $19.87 M(+12.3%) |
Jun 2021 | - | $7.36 M(+69.4%) | $17.69 M(+24.7%) |
Mar 2021 | - | $4.34 M(+38.2%) | $14.18 M(-4.5%) |
Dec 2020 | $14.85 M(-38.7%) | $3.14 M(+10.2%) | $14.85 M(-12.7%) |
Sep 2020 | - | $2.85 M(-25.9%) | $17.00 M(-15.5%) |
Jun 2020 | - | $3.85 M(-23.1%) | $20.13 M(-13.4%) |
Mar 2020 | - | $5.01 M(-5.5%) | $23.25 M(-3.9%) |
Dec 2019 | $24.21 M(-8.6%) | $5.30 M(-11.4%) | $24.21 M(-8.6%) |
Sep 2019 | - | $5.98 M(-14.2%) | $26.49 M(+0.1%) |
Jun 2019 | - | $6.97 M(+17.0%) | $26.46 M(-8.9%) |
Mar 2019 | - | $5.96 M(-21.4%) | $29.05 M(+13.6%) |
Dec 2018 | $26.48 M(+880.1%) | $7.58 M(+27.6%) | $25.57 M(+42.2%) |
Sep 2018 | - | $5.95 M(-37.8%) | $17.98 M(+43.5%) |
Jun 2018 | - | $9.56 M(+285.5%) | $12.53 M(+265.0%) |
Mar 2018 | - | $2.48 M(+404.1%) | $3.43 M(+133.8%) |
Dec 2017 | $2.70 M(+85.4%) | - | - |
Sep 2017 | - | $492.00 K(+6.6%) | $1.47 M(+6.2%) |
Jun 2017 | - | $461.70 K(+114.6%) | $1.38 M(+36.5%) |
Jun 2017 | $1.46 M(+3.2%) | - | - |
Mar 2017 | - | $215.10 K(-28.3%) | $1.01 M(-10.3%) |
Dec 2016 | - | $300.10 K(-26.1%) | $1.13 M(-8.2%) |
Sep 2016 | - | $406.00 K(+343.2%) | $1.23 M(-12.8%) |
Jun 2016 | $1.41 M(-48.5%) | $91.60 K(-72.4%) | $1.41 M(+40.2%) |
Mar 2016 | - | $331.60 K(-17.3%) | $1.01 M(-40.9%) |
Dec 2015 | - | $401.10 K(-31.7%) | $1.70 M(-33.4%) |
Sep 2015 | - | $587.30 K(-287.8%) | $2.55 M(-6.8%) |
Jun 2015 | $2.74 M(+5.0%) | -$312.80 K(-130.5%) | $2.74 M(-1.7%) |
Mar 2015 | - | $1.03 M(-18.0%) | $2.79 M(-4.6%) |
Dec 2014 | - | $1.25 M(+61.8%) | $2.93 M(+15.6%) |
Sep 2014 | - | $774.60 K(-392.3%) | $2.53 M(-3.1%) |
Jun 2014 | $2.61 M(+24.3%) | -$265.00 K(-122.8%) | $2.61 M(-12.5%) |
Mar 2014 | - | $1.16 M(+35.5%) | $2.99 M(+25.7%) |
Dec 2013 | - | $858.10 K(+0.2%) | $2.38 M(+6.7%) |
Sep 2013 | - | $856.60 K(+685.2%) | $2.23 M(+5.9%) |
Jun 2013 | $2.10 M(-7.1%) | $109.10 K(-80.2%) | $2.10 M(-1.6%) |
Mar 2013 | - | $551.40 K(-22.2%) | $2.14 M(-0.8%) |
Dec 2012 | - | $709.00 K(-3.2%) | $2.15 M(-8.3%) |
Sep 2012 | - | $732.70 K(+409.9%) | $2.35 M(+3.8%) |
Jun 2012 | $2.26 M | $143.70 K(-74.7%) | $2.26 M(-5.0%) |
Mar 2012 | - | $567.90 K(-37.2%) | $2.38 M(+0.0%) |
Dec 2011 | - | $904.60 K(+40.0%) | $2.38 M(+9.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2011 | - | $646.00 K(+145.2%) | $2.18 M(-1.0%) |
Jun 2011 | $2.21 M(-6.1%) | $263.50 K(-53.6%) | $2.21 M(-13.7%) |
Mar 2011 | - | $567.50 K(-19.7%) | $2.56 M(+0.5%) |
Dec 2010 | - | $706.70 K(+5.7%) | $2.54 M(+0.8%) |
Sep 2010 | - | $668.90 K(+9.0%) | $2.52 M(+7.4%) |
Jun 2010 | $2.35 M(+6.5%) | $613.80 K(+10.6%) | $2.35 M(+5.3%) |
Mar 2010 | - | $555.00 K(-19.0%) | $2.23 M(+1.0%) |
Dec 2009 | - | $685.40 K(+38.5%) | $2.21 M(+1.7%) |
Sep 2009 | - | $495.00 K(+0.1%) | $2.17 M(-1.6%) |
Jun 2009 | $2.21 M(-3.7%) | $494.60 K(-7.1%) | $2.21 M(+2.6%) |
Mar 2009 | - | $532.20 K(-18.0%) | $2.15 M(-13.8%) |
Dec 2008 | - | $649.10 K(+22.5%) | $2.50 M(+2.6%) |
Sep 2008 | - | $529.90 K(+20.6%) | $2.43 M(+6.1%) |
Jun 2008 | $2.29 M(-5.0%) | $439.40 K(-49.9%) | $2.29 M(+1.2%) |
Mar 2008 | - | $877.00 K(+49.7%) | $2.26 M(+19.1%) |
Dec 2007 | - | $585.90 K(+50.6%) | $1.90 M(-21.4%) |
Sep 2007 | - | $389.10 K(-5.5%) | $2.42 M(+0.2%) |
Jun 2007 | $2.41 M(+25.7%) | $411.60 K(-20.0%) | $2.41 M(-0.3%) |
Mar 2007 | - | $514.20 K(-53.4%) | $2.42 M(+3.7%) |
Dec 2006 | - | $1.10 M(+187.9%) | $2.34 M(+31.2%) |
Sep 2006 | - | $383.30 K(-8.7%) | $1.78 M(-7.2%) |
Jun 2006 | $1.92 M(-5.4%) | $420.00 K(-2.0%) | $1.92 M(-3.7%) |
Mar 2006 | - | $428.60 K(-21.9%) | $1.99 M(-3.9%) |
Dec 2005 | - | $548.70 K(+5.0%) | $2.08 M(+0.5%) |
Sep 2005 | - | $522.40 K(+5.6%) | $2.07 M(+1.8%) |
Jun 2005 | $2.03 M(-30.2%) | $494.50 K(-3.1%) | $2.03 M(-15.8%) |
Mar 2005 | - | $510.40 K(-5.1%) | $2.41 M(+9.9%) |
Dec 2004 | - | $538.10 K(+10.6%) | $2.19 M(-2.6%) |
Sep 2004 | - | $486.40 K(-44.5%) | $2.25 M(-22.5%) |
Jun 2004 | $2.91 M(+95.8%) | $876.20 K(+197.9%) | $2.91 M(+25.2%) |
Mar 2004 | - | $294.10 K(-50.8%) | $2.32 M(-0.0%) |
Dec 2003 | - | $597.50 K(-47.6%) | $2.32 M(+4.6%) |
Sep 2003 | - | $1.14 M(+291.4%) | $2.22 M(+49.6%) |
Jun 2003 | $1.48 M(-23.6%) | $291.10 K(-1.1%) | $1.48 M(-31.3%) |
Mar 2003 | - | $294.40 K(-40.7%) | $2.16 M(-0.3%) |
Dec 2002 | - | $496.30 K(+23.2%) | $2.17 M(-11.7%) |
Sep 2002 | - | $402.90 K(-58.4%) | $2.45 M(-1.3%) |
Jun 2002 | $1.94 M(+30.3%) | $967.50 K(+222.1%) | $2.49 M(+36.4%) |
Mar 2002 | - | $300.40 K(-61.6%) | $1.82 M(-1.8%) |
Dec 2001 | - | $782.60 K(+80.1%) | $1.86 M(+22.0%) |
Sep 2001 | - | $434.60 K(+42.8%) | $1.52 M(+2.0%) |
Jun 2001 | $1.49 M(-24.3%) | $304.40 K(-8.8%) | $1.49 M(-18.0%) |
Mar 2001 | - | $333.60 K(-25.6%) | $1.82 M(-10.3%) |
Dec 2000 | - | $448.20 K(+10.5%) | $2.03 M(+2.4%) |
Sep 2000 | - | $405.50 K(-35.8%) | $1.98 M(+25.8%) |
Jun 2000 | $1.97 M(+100.6%) | $631.30 K(+16.5%) | $1.57 M(+67.0%) |
Mar 2000 | - | $541.70 K(+35.4%) | $941.70 K(+135.4%) |
Dec 1999 | - | $400.00 K | $400.00 K |
Jun 1999 | $982.40 K | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual SGA year-on-year change?
- What is Eloxx Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly SGA year-on-year change?
- What is Eloxx Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM SGA year-on-year change?
What is Eloxx Pharmaceuticals annual SGA?
The current annual SGA of ELOX is $10.69 M
What is the all time high annual SGA for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual SGA is $26.48 M
What is Eloxx Pharmaceuticals annual SGA year-on-year change?
Over the past year, ELOX annual SGA has changed by -$9.76 M (-47.71%)
What is Eloxx Pharmaceuticals quarterly SGA?
The current quarterly SGA of ELOX is $2.39 M
What is the all time high quarterly SGA for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly SGA is $9.56 M
What is Eloxx Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ELOX quarterly SGA has changed by +$125.00 K (+5.53%)
What is Eloxx Pharmaceuticals TTM SGA?
The current TTM SGA of ELOX is -$1.13 B
What is the all time high TTM SGA for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM SGA is -$2.20 M
What is Eloxx Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ELOX TTM SGA has changed by -$1.14 B (-9762.78%)